FDA Inspection
Tianjin Zhongan Pharmaceutical Co., Ltd.Tianjin Zhongan Pharmaceutical Co., Ltd. – FDA Inspection, Feb 2, 2016
Record Details
This FDA Inspection record concerns Tianjin Zhongan Pharmaceutical Co., Ltd., with an inspection on February 2, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 2, 2016
- Product Type
- Drugs
View Company Profile
ID · 17c57f4f-0a27-4b9f-8777-95adb60ba223
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 956512
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Tianjin Zhongan Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 23, 2025 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| September 27, 2013 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tianjin Zhongan Pharmaceutical Co., Ltd.
- FDA Inspection 1289190 - 2025-10-23
- FDA Inspection 851023 - 2013-09-27
- FDA Inspection 672160 - 2010-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.